{"id":"W4378903121","doi":"10.1182/bloodadvances.2023010281","title":"Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of British Columbia; Pediatric Oncology Group","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Cyclophosphamide; Cumulative incidence; Internal medicine; Tacrolimus; Incidence (geometry); Transplantation; Graft-versus-host disease; Myelodysplastic syndromes; Bone marrow; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001990832,0.0002306197,0.000535113,0.0001822834,0.00007927013,0.00000848068,0.00009660002,0.0000904585,0.00001426799],"category_scores_gemma":[0.00005325854,0.0001743792,0.00012318,0.0006680312,0.00008840032,0.0001704414,0.000008163947,0.0001258228,0.00001732103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000333203,"about_ca_system_score_gemma":0.0002474362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001189542,"about_ca_topic_score_gemma":0.00001202528,"domain_scores_codex":[0.9983763,0.00002638613,0.0004334521,0.0003989376,0.0004219751,0.0003429337],"domain_scores_gemma":[0.9988206,0.0004506849,0.0002121347,0.0002112535,0.0001979241,0.0001074093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.4192631,0.002859455,0.4636869,0.01350474,0.004747343,0.002055919,0.0192808,0.0008956293,0.0625961,0.005678434,0.0004467842,0.004984777],"study_design_scores_gemma":[0.290067,0.01545093,0.1148127,0.001109835,0.008324772,0.0004448642,0.001337248,0.000163694,0.5639774,0.002359487,0.001006936,0.0009452556],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992224,0.0005872546,0.001328239,0.0001705434,0.0002282676,0.003181705,0.0002830675,0.0002009029,0.001796059],"genre_scores_gemma":[0.9883101,0.002778368,0.00699482,0.00004177137,0.0003318744,0.000510196,0.0001722776,0.00005835227,0.0008022319],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5013812,"threshold_uncertainty_score":0.7110977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01346082217133303,"score_gpt":0.282818043183776,"score_spread":0.269357221012443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}